Comparison of Outcomes of Percutaneous MitraClip Versus Surgical Repair or Replacement for Degenerative Mitral Regurgitation in Octogenarians

被引:26
作者
Buzzatti, Nicola [1 ]
Maisano, Francesco [2 ]
Latib, Azeem [1 ]
Taramasso, Maurizio [2 ]
Denti, Paolo [1 ]
La Canna, Giovanni [1 ]
Colombo, Antonio [1 ]
Alfieri, Ottavio [1 ]
机构
[1] Ist Sci San Raffaele, Cardiac Surg Dept, I-20132 Milan, Italy
[2] Univ Zurich Hosp, Dept Cardiovasc Surg, CH-8091 Zurich, Switzerland
关键词
VALVE REPAIR; RISK PATIENTS; SURGERY; THERAPY; FAILURE; SYSTEM;
D O I
10.1016/j.amjcard.2014.11.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Octogenarians affected by mitral regurgitation (MR) are an increasing high-risk population. MitraClip repair is emerging as a promising option for this kind of patients. In this retrospective study, the outcomes of patients aged >= 13 years, affected by isolated degenerative MR, who underwent isolated transcatheter (n = 25) or surgical (n = 35, 29 repairs and 6 replacements) mitral intervention from September 2008 to February 2014 were compared. MitraClip patients had higher mean age (84.5 +/- 3.2 vs 81.9 +/- 2.0 years, p <0.01), median Logistic Euroscore 19.4 (11.1 to 29.0) versus 8.4 (7.0 to 10.1) (p <0.01), median Society of Thoracic Surgeons predicted mortality 5.3 (3.5 to 6.6) versus 2.7 (2.3 to 3.9) (p <0.01), and more advanced New York Heart Association class (III to IV in 68% vs 37%, p = 0.02). At 30 days, 1 death occurred in the MitraClip group (p = 0.2). MitraClip was associated with significantly less complications (p <0.05) but more residual MR >2 (p <0.01). Two-year actuarial survival rate was 90% for MitraClip versus 97% for surgery (p <0.01). Higher Society of Thoracic Surgeons mortality was associated with reduced follow-up survival rate (p = 0.01). Two-year actuarial freedom from MR >2 was 70% versus 100%, respectively (p <0.01). New York Heart Association class and quality of life improved after MitraClip and were similar to surgical patients. Recurrent MR >2 was not significantly associated with follow-up mortality in this elderly setting. After the introduction of MitraClip, octogenarian patients with isolated degenerative MR receiving mitral treatment significantly increased (p <0.01). In conclusion, MitraClip patients, despite being older, more symptomatic, and affected by more co-morbidities showed significantly reduced postoperative complications. Two-year mortality was higher in the MitraClip group likely because of co-morbidities. Transcatheter mitral repair resulted in more octogenarians being treated compared with the past. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 50 条
  • [31] Management of mitral regurgitation in Marfan syndrome: Outcomes of valve repair versus replacement and comparison with myxomatous mitral valve disease
    Helder, Meghana R. K.
    Schaff, Hartzell V.
    Dearani, Joseph A.
    Li, Zhuo
    Stulak, John M.
    Suri, Rakesh M.
    Connolly, Heidi M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (03) : 1020 - 1024
  • [32] Minimally invasive mitral valve repair for functional mitral regurgitation in severe heart failure: MitraClip versus minimally invasive surgical approach
    Ondrus, Tomas
    Bartunek, Jozef
    Vanderheyden, Marc
    Stockman, Bernard
    Kotrc, Martin
    Van Praet, Frank
    Van Camp, Guy
    Lecomte, Patrick
    Mo, Yujing
    Penicka, Martin
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2016, 23 (05) : 784 - 789
  • [33] Surgical versus transcatheter repair for secondary mitral regurgitation: A propensity score-matched cohorts comparison
    Okuno, Taishi
    Praz, Fabien
    Kassar, Mohammad
    Biaggi, Patric
    Mihalj, Maks
    Kulling, Mischa
    Widmer, Sonja
    Pilgrim, Thomas
    Grunenfelder, Jurg
    Kadner, Alexander
    Corti, Roberto
    Windecker, Stephan
    Wenaweser, Peter
    Reineke, David
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 165 (06) : 2037 - 2046.e4
  • [34] Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation
    Frangieh, Antonio H.
    Gruner, Christiane
    Mikulicic, Fran
    Attinger-Toller, Adrian
    Tanner, Felix C.
    Taramasso, Maurizio
    Corti, Roberto
    Grunenfelder, Jurg
    Luscher, Thomas F.
    Ruschitzka, Frank
    Bettex, Dominique
    Maisano, Francesco
    Gaemperli, Oliver
    EUROINTERVENTION, 2016, 11 (14) : E1680 - E1686
  • [35] Comparison of Mitral Valve Replacement and Repair for Degenerative Mitral Regurgitation: a Meta-analysis and Implications for Transcatheter Mitral Procedures
    Overtchouk, P.
    Ben-Ali, W.
    Prendergast, B.
    Conradi, L.
    Hahn, R.
    Granada, J.
    Modine, T.
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (09)
  • [36] Percutaneous treatment of mitral regurgitation with MitraClip device
    Pregowski, Jerzy
    Witkowski, Adam
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2013, 9 (04): : 383 - 389
  • [37] Comparison of Percutaneous Mitral Valve Repair Versus Conservative Treatment in Severe Functional Mitral Regurgitation
    Giannini, Cristina
    Fiorelli, Francesca
    De Carlo, Marco
    Guarracino, Fabio
    Faggioni, Michela
    Giordano, Paolo
    Spontoni, Paolo
    Pieroni, Andrea
    Petronio, Anna Sonia
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (02) : 271 - 277
  • [38] Is ischemic mitral regurgitation an indication for surgical repair or replacement?
    Gillinov, A. Marc
    HEART FAILURE REVIEWS, 2006, 11 (03) : 231 - 239
  • [39] Is ischemic mitral regurgitation an indication for surgical repair or replacement?
    A. Marc Gillinov
    Heart Failure Reviews, 2006, 11 : 231 - 239
  • [40] Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial
    Reichenspurner, Hermann
    Schillinger, Wolfgang
    Baldus, Stephan
    Hausleiter, Joerg
    Butter, Christian
    Schaeefer, Ulrich
    Pedrazzini, Giovanni
    Maisano, Francesco
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 44 (04) : E280 - E288